📰 Nasdaq Twst News
Nasdaq Twst News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Nasdaq Twst. Real-time updates on events, politics, business and more.
May 6, 2024
Twist Bioscience (NASDAQ:TWST – Free Report) had its price target boosted by Evercore ISI from $46.00 to $50.00 in a report issued on Friday morning, Benzinga reports. Evercore ISI currently has an outperform rating on the stock. Several other brokerages also recently issued reports on TWST. Robert W. Baird lifted their price objective on Twist […]
May 6, 2024
Twist Bioscience (NASDAQ:TWST – Get Free Report) had its price target lifted by Scotiabank from $43.00 to $48.00 in a report released on Monday, Benzinga reports. The brokerage presently has a “sector outperform” rating on the stock. Scotiabank’s price objective would indicate a potential upside of 7.43% from the company’s current price. Several other equities […]
May 4, 2024
Twist Bioscience (NASDAQ:TWST – Get Free Report) had its price objective hoisted by investment analysts at Evercore ISI from $46.00 to $50.00 in a research report issued to clients and investors on Friday, Benzinga reports. The firm currently has an “outperform” rating on the stock. Evercore ISI’s target price would indicate a potential upside of […]
April 25, 2024
Twist Bioscience Co. (NASDAQ:TWST – Get Free Report) COO Patrick John Finn sold 2,174 shares of the firm’s stock in a transaction that occurred on Tuesday, April 23rd. The shares were sold at an average price of $30.12, for a total value of $65,480.88. Following the sale, the chief operating officer now owns 176,206 shares […]
April 25, 2024
Twist Bioscience Co. (NASDAQ:TWST – Get Free Report) COO Patrick John Finn sold 2,174 shares of the business’s stock in a transaction dated Tuesday, April 23rd. The shares were sold at an average price of $30.12, for a total transaction of $65,480.88. Following the completion of the sale, the chief operating officer now directly owns […]
April 10, 2024
Twist Bioscience Co. (NASDAQ:TWST – Get Free Report) shares gapped down before the market opened on Wednesday . The stock had previously closed at $33.73, but opened at $31.32. Twist Bioscience shares last traded at $31.44, with a volume of 94,932 shares changing hands. Analysts Set New Price Targets TWST has been the topic of […]
March 11, 2024
Twist Bioscience Co. (NASDAQ:TWST – Get Free Report) SVP Paula Green sold 600 shares of the company’s stock in a transaction on Wednesday, March 6th. The shares were sold at an average price of $37.43, for a total value of $22,458.00. Following the sale, the senior vice president now owns 92,850 shares of the company’s […]
March 1, 2024
Deutsche Bank AG increased its holdings in Twist Bioscience Co. (NASDAQ:TWST – Free Report) by 4.8% in the third quarter, HoldingsChannel.com reports. The firm owned 51,208 shares of the company’s stock after buying an additional 2,368 shares during the quarter. Deutsche Bank AG’s holdings in Twist Bioscience were worth $1,037,000 at the end of the […]
March 1, 2024
Charles Schwab Investment Management Inc. raised its holdings in shares of Twist Bioscience Co. (NASDAQ:TWST – Free Report) by 3.4% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 442,504 shares of the company’s stock after purchasing an additional 14,511 […]
February 20, 2024
Citigroup Inc. increased its holdings in shares of Twist Bioscience Co. (NASDAQ:TWST – Free Report) by 94.1% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 264,204 shares of the company’s stock after buying an additional 128,098 shares during the quarter. Citigroup Inc. owned 0.46% […]